|
⚲
|
| Keyboard |
| Intellia Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001652130 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001652130] | |
| 10-Q | [0001652130] | |
| 3 | [0001652130] | |
| 4 | [0001652130] | |
| 5 | [0001652130] | |
| 8-K | [0001652130] | |
| D | [0001652130] | |
| SC 13D | [0001652130] | |
| SC 13G | [0001652130] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Intellia Therapeutics Inc | |
| Dulac Edward J III | |
| Dube Michael P | |
| Bhanji Muna | |
| Goodman Jesse | |
| Cohen Fred E | |
| Goff Brian | |
| Keresty Georgia | |
| Verwiel Frank | |
| Chase William J | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-02 | Sell | 607 | $13.78 | 8,364 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-02 | Sell | 1,211 | $13.78 | 16,688 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 17,250 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 10,505 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 56,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 9,943 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 14,204 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 156,400 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 61,280 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 65,829 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 46,080 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 87,543 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 7,353 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 39,200 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 225,400 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 34,146 | $9.21 | 314,485 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Buy | 150,000 | $9.35 | 1,402,500 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 9,515 | $9.21 | 87,633 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 10,397 | $9.21 | 95,756 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 2,989 | $9.21 | 27,529 |
| showing 20 of 200 most recent transactions | |||||